跳至主要内容
临床试验/NCT03976596
NCT03976596终止不适用

Measurement of in Vivo Mitochondrial Capacity in Infants: a 31P-MRS Pilot Study

Pennington Biomedical Research Center1 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2019年5月21日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
2
试验地点
1
主要终点
In vivo mitochondrial capacity (ATPmax)

研究概览

简要总结

The overarching aim of this project is to determine the test re-test reliability of 31P-magnetic resonance spectroscopy measurements in infants. Primary endpoints include two separate measures of in vivo mitochondrial capacity (ATPmax) over a 1-10 day period to assess feasibility and reliability.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
14 Days 至 28 Days(Child)
性别
All
接受健康志愿者

入选标准

  • healthy, full-term infant
  • aged 14-28 days at Visit 1
  • willingness of parents to be notified of incidental findings from study procedures

排除标准

  • born preterm
  • implanted metal or electronic objects that render MRI unsafe
  • unable to complete 2 clinic visits 1-10 days apart at Pennington Biomedical Research Center

结局指标

主要结局

In vivo mitochondrial capacity (ATPmax)

时间窗: 1 day

In vivo mitochondrial capacity as measured by phosphorus magnetic resonance spectroscopy

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Leanne Redman

Associate Professor

Pennington Biomedical Research Center

研究点 (1)

Loading locations...

相似试验